Chapter 4.3 Substance P (NK 1 receptor) antagonists

Techniques in the Behavioral and Neural Sciences

Volumn 15, Issue PART 2, 2005, Pages 423-435

  Rupniak, Nadia M J ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956710118     PISSN: 09210709     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0921-0709(05)80067-7     Document Type: Chapter

References (112)

1. Accarino A.M., Azpiroz F., and Malagelada J.R. Selective dysfunction of mechanosensitive intestinal afferents in irritable bowel syndrome. Gastroenterology 108 (1995) 636-643
2. Aguiar M.S., and Brandao M.L. Effects of microinjections of the neuropeptide substance P in the dorsal periaqueductal gray on the behaviour of rats in the plus-maze test. Physiol. Behav. 60 (1996) 1183-1186
3. Ameringen M.V., Mancini C., Farvolden P., et al. Drugs in development for social anxiety disorder: more to social anxiety than meets the SSRI. Expert Opin. Investig. Drugs 9 (2002) 2215-2231
4. Arai H., and Emson P.C. Regional distribution of neuropeptide K and other tachykinins (neurokinin A, neurokinin B and substance P) in rat central nervous system. Brain Res. 399 (1986) 240-249
5. Arinami T., Li L., Mitsushio H., Itokawa M., et al. An insertion/deletion polymorphism in the angiotensin converting enzyme gene is associated with both brain substance P contents and affective disorders. Biol. Psychiat. 40 (1996) 1122-1127
6. Baghai T.C., Schule C., Zwanzger P., et al. Hypothalamic-pituitary-adrenocortical axis dysregulation in patients with major depression is influenced by the insertion/deletion polymorphism in the angiotensin I-converting enzyme gene. Neurosci. Lett. 328 (2002) 299-303
7. Ballard T.M., Sanger S., and Higgins G.A. Inhibition of shock-induced foot tapping behaviour in the gerbil by a tachykinin N.K.(1) receptor antagonist. Eur. J. Pharmacol. 412 (2001) 255-264b
8. Bondy B., Baghai T.C., Minov C., et al. Substance P serum levels are increased in major depression: preliminary results. Biol. Psychiatry 53 (2003) 538-542
9. Bondy B., Baghai T.C., Zill P., et al. Combined action of the ACE D- and the G-protein beta3 T-allele in major depression: a possible link to cardiovascular disease?. Mol. Psychiat. 7 (2002) 1120-1126
10. 1 receptor) antagonist L-760735 inhibits neonatal vocalisation in guinea-pigs. Neuropharmacology 41 (2001) 130-137
11. 1 receptor in the colon of female rats: involvement of steroids. Gut. 50 (2002) 349-354
12. 1 receptor activation in gerbils. Eur. J. Pharmacol. 254 (1994) 245-249
13. Brodin E., Rosen A., Schott E., et al. Effects of sequential removal of rats from a group cage, and of individual housing of rats, on substance P, cholecystokinin and somatostatin levels in the periaqueductal grey and limbic regions. Neuropeptides 26 (1994) 253-260
14. 1A agonist 8-OH-DPAT in the social interaction test in gerbils. Brain Res. 915 (2001) 170-175
15. Chen Z.B., Hedner J., and Hedner T. Local effects of substance P on respiratory regulation in the rat medulla oblongata. J. Appl. Physiol. 68 (1990) 693-699
16. Chowdrey H.S., Jessop D.S., and Lightman S.L. Substance P stimulates arginine vasopressin and inhibits adrenocorticotropin release in vivo in the rat. Neuroendocrinology 52 (1990) 90-93
17. Clark M.M., and Galef B.G. The role of the physical rearing environment in the domestication of the Mongolian gerbil (Meriones unguiculatus). Anim. Behav. 25 (1977) 298-316
18. Coiro V., Capretti L., Volpi R., et al. Stimulation of ACTH/cortisol by intravenously infused substance P in normal men: inhibition by sodium valproate. Neuroendocrinology 56 (1992) 459-463
19. Couture R., Picard P., Poulat P., et al. Characterization of the tachykinin receptors involved in spinal and supraspinal cardiovascular regulation. Can. J. Physiol. Pharmacol. 73 (1995) 892-902
20. Croci T., Landi M., Emonds-Alt X., et al. Role of tachykinins in castor oil diarrhoea in rats. Brit. J. Pharmacol. 121 (1997) 375-380
21. Culman J., Klee S., Ohlendorf C., et al. Effect of tachykinin receptor inhibition in the brain on cardiovascular and behavioral responses to stress. J. Pharmacol. Exp. Ther. 280 (1997) 238-246
22. Daly M., and Daly S. Socio-ecology of Saharan gerbils, especially meriones libycus. Mammalia 39 (1975) 282-311
23. da Vanzo J.P., Daugherty M., Ruckart R., et al. Pharmacological and biochemical studies in isolation-induced fighting mice. Psychopharmacologia 9 (1966) 210-219
24. de Felipe C., Herrero J.F., O'Brien J.A., et al. Altered nociception, analgesia and aggression in mice lacking the receptor for substance P. Nature 392 (1998) 394-397
25. de Palatis L., Fiorindo R., and Ho R. Subsance P immunoreactivity in the anterior pituitary gland of the guinea pig. Endocrinology 110 (1982) 282-286
26. Dubinsky B., and Goldberg M.E. The effect of imipramine and selected drugs on attack elicited by hypothalamic stimulation in the cat. Neuropharmacology 10 (1971) 537-545
27. Faria M., Navarra P., Tsagarakis S., et al. Inhibition of CRF-41 release by substance P, but not substance K, from the rat hypothalamus in vitro. Brain Res. 538 (1991) 76-78
28. Fehder W.P., Sachs J., Uvaydova M., et al. Substance P as an immune modulator of anxiety. Neuroimmunomodulation 4 (1997) 42-48
29. File S.E. Anxiolytic action of a neurokinin-1 receptor antagonist in the social interaction test. Pharmacol. Biochem. Behav. 58 (1997) 747-752
30. 1 receptor antagonist, has an anxiolytic action in the social interaction test. Psychopharmacology 152 (2000) 105-109
31. Furlong R.A., Keramatipour M., Ho L.W., et al. No association of an insertion/deletion polymorphism in the angiotensin I converting enzyme gene with bipolar or unipolar affective disorders. Am. J. Med. Genet. 96 (2000) 733-735
32. Gentsch C., Cutler M., Vassout A., et al. Anxiolytic effect of NKP608, a NK1-receptor antagonist, in the social investigation test in gerbils. Behav. Brain Res. 133 (2002) 363-368
33. Gorman J.M., Kent J.M., Sullivan G., et al. Neuroanatomical hypothesis of panic disorder, revised. Am. J. Psychiatry 157 (2000) 493-505
34. Graham E.A., Turpin M.P., and Stubbs C.M. Characterisation of the tachykinin-induced hindlimb thumping response in gerbils. Neuropeptides 4 (1993) 228
35. Gray P.A., Janczewski W.A., Mellen N., et al. Normal breathing requires preBotzinger complex neurokinin-1 receptor-expressing neurons. Nature Neurosci. 4 (2001) 927-930
36. Gray T.S., and Magnuson D.J. Peptide immunoreactive neurons in the amygdala and the bed nucleus of the stria terminalis project to the midbrain central gray in the rat. Peptides 13 (1992) 451-460
37. 1 receptors in the rat. J. Neurophysiol. 86 (2001) 438-446
38. Hinson J.P., Purbrick A., Cameron L.A., et al. The role of neuropeptides in the regulation of adrenal zona fasciculata/reticularis function. Effects of vasoactive intestinal polypeptide, substance P, neuropeptide Y, met- and leuenkephalin and neurotensin on corticosterone secretion in the intact perfused rat adrenal gland in situ. Neuropeptides 26 (1994) 391-397
39. Hokfelt, et al. Distribution of neuropeptides with special reference to their coexistence with classic transmitters. In: Meltzer H.Y. (Ed). Psychopharmacology: The Third Generation of progress (1987), Raven Press, New York
40. Holsboer F., and Barden N. Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endoc. Rev. 17 (1996) 187-205
41. Holzer P. Different contractile effects of substance P on the intestine of mammals. Naunyn. Schmied. Arch. Pharmacol 320 (1982) 217-220
42. Holzer P., Holzer-Petsche U., and Leander S. A tachykinin antagonist inhibits gastric emptying and gastro-intestinal transit in the rat. Br. J. Pharmacol. 89 (1986) 453-459
43. Horovitz Z.P. Selective block of rat mouse killing by antidepressants. Life Sci. 4 (1965) 1909-1912
44. Ikeda K., Miyata K., Orita A., et al. RP67580, a neurokinin-1 receptor antagonist, decreased restraint stress-induced defecation in rat. Neurosci. Lett. 198 (1995) 103-110
45. Itoi K., Jost N., Culman J., et al. Further localization of cardiovascular and behavioral actions of substance P in the rat brain. Brain Res. 668 (1994) 100-106
46. Jessop D.S., Renshaw D., Larsen P.J., et al. Substance P is involved in terminating the hypothalamo-pituitary-adrenal axis response to acute stress through centrally located neurokinin-1 receptors. Stress 3 (2000) 209-220
47. Joos G.F., Van Schoor J., Kips J.C., et al. The effect of inhaled FK224, a tachykinin NK-1 and NK-2 receptor antagonist, on neurokinin A-induced bronchoconstriction in asthmatics. Am. J. Respir. Crit. Care Med. 153 (1996) 1781-1784
48. Julia V., Morteau O., and Bueno L. Involvement of neurokinin 1 and 2 receptors in viscerosensitive response to rectal distension in rats. Gastroenterology 107 (1994) 94-102
49. Klein D.F. False suffocation alarms, spontaneous panic, and related conditions. Arch. Gen. Psychiatry 50 (1993) 306-317
50. Kramer M.S., Cutler N., Feighner J., et al. Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science 281 (1998) 1640-1645
51. Kramis R.C., and Routtenberg A. Rewarding brain stimulation, hippocampal activity, and foot stomping in the gerbil. Physiol. Behav. 4 (1968) 7-11
52. Kris M.G., Redford J., Pizzo B., et al. Dose ranging antiemetic trial of the NK-1 receptor antagonist CP-122,721: A new approach for acute and delayed emesis following cisplatin. Proc. Am. Soc. Clin Oncol. 15 (1996) 547
53. Krowicki Z.K., and Hornby P.J. Substance P in the dorsal motor nucleus of the vagus evokes gastric motor inhibition via neurokinin-1 receptor in rat. J. Pharmacol. Exp. Ther. 293 (2000) 214-221
54. Ku Y.H., Tan L., Li L.S., et al. Role of corticotropin-releasing factor and substance P in pressor responses of nuclei controlling emotion and stress. Peptides 19 (1998) 677-682
55. Laird J.M.A., Olivar T., Roza C., et al. Deficits in viseeral pain and hyperalgesia of mice with a disruption of the tachykinin NK1 receptor gene. Neuroscience 98 (2000) 345-352
56. Larsen P.J., Jessop D., Patel H., et al. Substance P inhibits the release of anterior pituitary adrenocorticotrophin via a central mechanism involving corticotrophin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus. J. Neuroendocrinol. 5 (1993) 99-105
57. LeDoux J.E. Emotion: clues from the brain. Ann. Rev. Psychol. 46 (1995) 209-235
58. LeDoux J.E., and Muller J. Emotional memory and psychopathology. Phil. Trans. R. Soc. Lond. B. Biol. Sci. 352 (1997) 1719-1726
59. Abs 4439. Lee O.Y., Munakata J., Naliboff B.D., et al. A double blind parallel group pilot study of the effects of CJ-11,974 and placebo on perceptual and emotional responses to rectsigmoid distension in IBS patients. Gastroenterology 118 (2000)
60. Li H., and Li Y.Q. Collateral projection of substance P receptor expressing neurons in the medullary dorsal horn to bilateral parabrachial nuclei of the rat. Brain Res. Bull. 53 (2000) 163-169
61. Li J.L., Ding Y.Q., Xiong K.H., et al. Substance P receptor (NK1)-immunoreactive neurons projecting to the periaqueductal gray: distribution in the spinal trigeminal nucleus and the spinal cord of the rat. Neurosci. Res. 30 (1998) 219-225
62. Li Y.H., and Ku Y.H. Involvement of rat lateral septum-acetylcholine pressor system in central amygdaloid nucleus-emotional pressor circuit. Neurosci. Lett. 323 (2002) 60-144
63. Lieb K., Ahlvers K., Dancker K., et al. Effects of the neuropeptide substance P on sleep, mood, and neuroendocrine measures in healthy young men. Neuropsychopharmacology 27 (2002) 1041-1049
64. Liu H.L., Cao R., Jin L., et al. Immunocytochemical localization of substance P receptor in hypothalamic oxytocin-containing neurons of C57 mice. Brain Res. 948 (2002) 175-179
65. Maggi C.A., Catalioto R.M., Criscuoli M., et al. Tachykinin receptors and intestinal motility. Can. J. Physiol. Pharmacol. 75 (1997) 696-703
66. 3 H]SP as the radioligand. Brain Res. 307 (1984) 147-165
67. Mayer E.A. The neurobiology of stress and gastrointestinal disease. Gut. 47 (2000) 861-869
68. Maxwell P.R., Mendall M.A., and Kumar D. Irritable bowel syndrome. Lancet 350 (1997) 1691-1695
69. A and 5-HT anxiolytics. Psychopharmacology 121 (1995) 38-56
70. Mineka S., and Ohman A. Phobias and preparedness: the selective, automatic, and encapsulated nature of fear. Biol. Psychiat. 52 (2002) 927-937
71. Molewijk H.E., Hartog K., van der Poel A.M., et al. Reduction of guinea-pig pup isolation calls by anxiolytic and antidepressant drugs. Psychopharmacology 128 (1996) 31-38
72. Monnikes H., Schmidt B.G., and Tache Y. Psychological stress-induced accelerated colonic transit in rats involves hypothalamic corticotropin-releasing factor. Gastroenterology 104 (1993) 716-773
73. Murtra P., Sheasby A.M., Hunt S.P., et al. Rewarding effects of opiates are absent in mice lacking the receptor for substance P. Nature 405 (2000) 180-183
74. Pellow S., Chopin P., File S.E., et al. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods 14 (1985) 149-167
75. Perry M.J., and Lawson S.N. Differences in expression of oligosaccharides, neuropeptides, carbonic anhydrase and neurofilament in rat primary afferent neurons retrogradely labelled via skin, muscle or visceral nerves. Neuroscience 85 (1998) 293-310
76. Navari R.M., Reinhardt R.R., Gralla R.J., et al. Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. L-754,030 Antiemetic Trials Group. N. Engl. J. Med. 340 (1999) 190-195
77. Neri G., Andreis P.G., and Nussdorfer G.G. Effects of neuropeptide-Y and substance-P on the secretory activity of dispersed zona-glomerulosa cells of rat adrenal gland. Neuropeptides 17 (1990) 121-125
78. Newby D.E., Sciberras D.G., Ferro C.J., et al. Substance P-induced vasodilatation is mediated by the neurokinin type 1 receptor but does not contribute to basal vascular tone in man. Br. J. Clin. Pharmacol. 48 (1999) 336-344
79. O'Donnell C.J., Lindpainter K., Larson M.G., et al. Evidence from association and genetic linkage of the angiotensin converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation 97 (1998) 1766-1772
80. Okano S., Nagaya H., Ikeura Y., et al. Effects of TAK-637, a novel neurokinin-1 receptor antagonist, on colonic function in vivo. J. Pharmacol. Exp. Ther. 298 (2001) 559-564
81. Pauls J., Bandelow B., Ruther E., et al. Polymorphism of the gene of angiotensin converting enzyme: lack of association with mood disorder. J. Neural Transm. 107 (2000) 1361-1366
82. Payne A.P., Andrews M.J., and Wilson C.A. Housing, fighting and biogenic amines in the midbrain and hypothalamus of the golden hamster. Prog. Clin. Biol. Res. 167 (1984) 227-247
83. Randall J.A. Territorial defense and advertisement by foot drumming in bannertail kangaroo rats (Dipodomys spectabilis) at high and low population densities. Behav. Ecol. Sociobiol. 16 (1984) 11-20
84. Randall J.A., and Stevens C.M. Foot drumming and other anti-predator responses in the bannertail kangaroo rat Dipodomys spectabilis. Behav. Ecol. Sociobiol. 20 (1987) 187-194
85. Reuss S., and Burger K. Substance P-like immunoreactivity in the hypothalamic suprachiasmatic nucleus of Phodopus sungorus-relation to daytime, photoperiod, sex and age. Brain Res. 638 (1994) 189-195
86. Ricciardi K.H., and Blaustein J.D. Projections from ventrolateral hypothalamic neurons containing progestin receptor- and substance P-immunoreactivity to specific forebrain and midbrain areas in female guinea pigs. J. Neuroendocrinol. 6 (1994) 135-144
87. Rozanski A., Blumenthal J.A., and Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 99 (1999) 2192-2217
88. Routtenberg A., and Kramis R.C. Foot-stomping in the gerbil: rewarding brain stimulation, sexual behaviour and foot shock. Nature 214 (1967) 173-174
89. 1 ) receptors attenuates neonatal vocalisation in guinea pigs and mice. Neuropharmacology 39 (2000) 1413-1421
90. 1 ) receptor in assays for antidepressant and anxiolytic drugs. Behav. Pharmacol. 12 (2001) 497-508
91. 1 ) antagonists. Trends Pharmacol. Sci. 20 (1999) 485-490
92. 1 ) Receptors by GR205171, RP67580, SR140333 and NKP608. Neuropharmacology 45 (2003) 231-241
93. 1 ) receptor antagonist L760735 inhibits fear conditioning in gerbils. Neuropharmacology 44 (2003) 516-523
94. 1 receptor antagonists. Eur. J. Pharmacol. 265 (1994) 179-183
95. Sanchez C., Arnt J., Hyttel J., et al. The role of serotinergic mechanisms in inhibition of isolation-induced aggression in male mice. Psychopharmacology 110 (1993) 53-57
96. Santarelli L., Gobbi G., Debs P.C., et al. Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function. Proc. Natl. Acad. Sci., USA. 98 (2001) 1912-1917
97. Schedlowski M., Fluge T., Richter S., et al. Beta-endorphin, but not substance-P, is increased by acute stress in humans. Psychoneuroendocrinology 20 (1995) 103-110
98. Shaikh M.B., Steinberg A., and Siegel A. Evidence that substance P is utilized in the medial amygdaloid facilitation of defensive rage behavior in the cat. Brain Res. 625 (1993) 283-294
99. Siegel R.A., Duker E.M., Pahnke U., et al. Stress-induced changes in cholecystokinin and substance P concentrations in discrete regions of the rat hypothalamus. Neuroendocrinology 46 (1987) 75-81
100. 1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets. Neuropharmacology 35 (1996) 1121-1129
101. 1 receptor antagonist CP-99,994. Neuropharmacology 33 (1994) 259-260
102. Teixeira R.M., Santos A.D., Ribiero S.J., et al. Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behaviour in mice. Eur. J. Pharmacol. 311 (1996) 7-14
103. Tiret L., Rigat B., Visvikis S., et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am. J. Hum. Genet. 51 (1992) 197-205
104. Tsukamoto M., Sarna S.K., and Condon R.E. A novel motility effect of tachykinins in normal and inflamed colon. Am. J. Physiol. 272 (1997) G1607-G1614
105. Unger T., Carolus S., Demmert G., et al. Substance P induces a cardiovascular defense reaction in the rat: pharmacological characterization. Circ. Res. 63 (1998) 812-820
106. Varty G.B., Cohen-Williams M.E., Morgan C.A., et al. The gerbil elevated plus-maze II. Anxiolytic-like effects of selective neurokinin NK1 receptor antagonists. Neuropsychopharmacology 27 (2002) 371-379
107. 1 receptor antagonist: behavioural effects. Neuropeptides 26 Suppl. 1 (1994) 38
108. Vassout A., Veenstra S., Hauser K., et al. NKP608: a selective NK-1 receptor antagonist with anxiolytic-like effects in the social interaction and social exploration test in rats. Regul. Peptides 96 (2000) 7-16
109. Vaupel R., Jarry H., Schlomer H.T., et al. Differential response of substance P-containing subtypes of adreno-medullary cells to different stressors. Endocrinology 123 (1998) 2140-2145
110. Von Euler U.S., and Gaddum J. An unidentified depressor substance in certain tissue extracts. J. Physiol. 72 (1931) 74-87
111. Weiss D.W., Hirt R., Tarcic N., et al. Studies in psychoneuroimmunology: psychological, immunological, and neuroendocrinological parameters in Israeli civilians during and after a period of Scud missile attacks. Behav. Med. 22 (1996) 5-14
112. Williams C.L., Villar R.G., Peterson J.M., et al. Stress-induced changes in intestinal transit in the rat: a model for irritable bowel syndrome. Gastroenterology 94 (1988) 611-621